Hepatocellular carcinoma (HCC) remains the sixth most commonly diagnosed malignancy
worldwide, still representing an important cause of cancer-related death. Over the next few …

Introduction Hepatocellular carcinoma (HCC) remains a frequently diagnosed malignancy
worldwide, still representing an important cause of cancer-related death. Recent years have …

Introduction Immunotherapy has recently taken on an extremely important role in medical
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …

Introduction Hepatocellular carcinoma (HCC) represents the sixth most commonly
diagnosed malignancy worldwide, accounting for millions of deaths annually. Despite …

The last three years have seen remarkable progress in comprehending predisposing factors
and upgrading our treatment arsenal concerning hepatocellular carcinoma (HCC). Until …

Introduction While sorafenib monotherapy represented the mainstay of medical treatment for
advanced hepatocellular carcinoma (HCC) patients for more than a decade, novel agents …

Liver cancer is the third leading cause of cancer death worldwide. Hepatocellular carcinoma
(HCC) is the most common primary malignant tumor of the liver. Liver resection or …

Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However,
recent years have seen the advent of several novel treatments in this setting, where the role …

Background Recent research has shown that selected patients with initially unresectable
hepatocellular carcinoma (HCC) are able to achieve conversion to resectable disease …

Liver cancer is a major global health concern, ranking among the top causes of cancer-
related deaths worldwide. Despite advances in medical research, the prognosis for liver …